Safety and Efficacy of Cefprozil as Part of a Parenteral-Oral Antibiotic Regimen for the Treatment of Suppurative Skeletal Infections in Children
Author(s) -
Mónica Trujillo,
S. Ehrett,
M. J. Hoyt-Sehnert,
S Shelton,
George H. McCracken
Publication year - 1996
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/clinids/23.4.843
Subject(s) - medicine , regimen , antibiotics , intensive care medicine , antibacterial agent , surgery , microbiology and biotechnology , biology
For more than two decades, combined parenteral-oral antimicrobial regimens have proved safe and effective for the treatment of osteomyelitis and suppurative arthritis in children [1-6]. We conducted this study to evaluate the safety and efficacy of oral cefprozil as follow-up therapy after initial treatment with parenteral antibiotics for suppurative osteoarticular infections in children. Twenty-five children younger than 13 years of age with a clinical diagnosis of osteomyelitis or suppurative arthritis who were admitted to Children's Medical Center or Parkland Memorial Hospital in Dallas were enrolled in the study between May 1993 and September 1994. Written informed consent for participation in the study was obtained in all cases. Laboratory studies performed at the time of admission included the following: WBC count with differential, erythrocyte sedimentation rate, C-reactive protein level, and blood culture. Orthopedic specialists were consulted for needle aspiration or surgical drainage of the affected site and for follow-up procedure(s), as clinically indicated. Intravenous antibiotic therapy was started at the time of diagnosis and continued until there was evidence of clinical improvement and a concomitant decrease over time in the indices of inflammation, at which time oral therapy with cefprozil (90 mg/kg given daily in three divided doses) was initiated. Serum inhibitory and serum bactericidal titers of antibodies to the patient's pathogen were determined by a standard microtiter method after the third dose of cefprozil was administered [7, 8]. The dosage of cefprozil was adjusted to achieve a serum bactericidal titer of ~ 1 :8. A pathogen was isolated from 12 patients. Staphylococcus aureus was the most common organism isolated, and no gramnegative pathogens were isolated. All isolates were susceptible to cefprozil (MIC, ,,;1.0 p,g/mL). Five patients (42%) each had osteomyelitis and suppurative arthritis and two (17%) had both. With the exception of one patient, serum bactericidal titers were
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom